Edgen Stock·Dec 12 2025, 01:38Back
Boston Scientific Deepens Cardiac Ablation Market Reach
Edgen Stock·Dec 12 2025, 01:38
[1] HeartBeam swells on turning FDA rejection into ECG clearance - Fierce Biotech (https://www.fiercebiotech.com/medtech/heartbe ...)[2] GRI touts IPF safety edge, lung function gains amid cash crunch - Fierce Biotech (https://www.fiercebiotech.com/biotech/gri-tou ...)[3] Privo Technologies Begins Dosing PRV131 in Arm 3 Of Clinical Study CLN-004, A First-In-Class Cisplatin Intratumoral Injectable Targeting Oral Cavity Cancer - BioSpace (https://www.biospace.com/press-releases/privo ...)
